Gene Expression in High-risk Breast and Ovarian Cancer Patients
Germline mutations in human BRCA 1 and BRCA2 genes confer a lifetime risk of breast cancer of between 60 and 85% and a lifetime risk of ovarian cancer of between 15 and 40%. Identification of mutations in these genes either in healthy carriers or in those who have already developed cancer is importa...
| Main Author: | |
|---|---|
| Published: |
Institute of Cancer Research (University Of London)
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504783 |